Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, announced it has partnered with Glooko, the leader in diabetes management mobile and web applications, to provide US OmniPod patients and healthcare providers a new data management system named "Insulet Provided Glooko".
This new system is available to patients who use the OmniPod System, as well as healthcare professionals who care for these patients.
"A critical component of diabetes management is the ability for patients, as well as their healthcare providers, to see a complete picture of their health," said Patrick Sullivan, president and chief executive officer.
"Having the ability to track and analyse information about a patient's insulin data, in combination with blood glucose levels, diet and exercise data, allows patients and their care teams to optimize and improve their healthcare management. We are pleased to partner with Glooko as Insulet's preferred data management partner and are thrilled to offer Glooko's award winning diabetes management platform with our OmniPod System."
With the Insulet Provided Glooko system, OmniPod patients are now able to view data from their OmniPod Personal Diabetes Manager (PDM), Continual Glucose Monitoring (CGM), Blood Glucose Meter (BGM) and fitness tracker on mobile devices, Macs or PCs and proactively share their data with family members and healthcare providers. The platform delivers a leading data management and analytics solution alongside Insulet's differentiated and unique tubeless OmniPod System.
This new system enables healthcare professionals to easily download patients' data from multiple devices and review a robust set of print and online reports during patient visits, including access to detailed insights about their patients' care plans. It also provides care teams with the ability to remotely monitor patients between visits and identify patients whose glucose levels are outside of a normal range or that are experiencing other clinical incidents.
The new Insulet Provided Glooko system has been well received by OmniPod patients and the healthcare professionals who care for these patients. Early feedback has been extremely positive, citing:
The reports are easy to read and fast to download;
The easy-to-use integrated kiosk streamlines patient flow and allows more time with patients;
Insulin, BG and CGM data together in one easy-to-use format improves the healthcare providers' ability to manage the health of their patients.
In addition, OmniPod patients now have access to Glooko's mobile app, available on iPhone and Android platforms, which allows them to view their OmniPod System data on their phone or tablet, together with their glucose (CGM and/or BGM), diet and exercise data. This "on-the-go" access to data provides patients continuous and more robust information to improve their diabetes management experience.
Insulet and Glooko have worked collaboratively to ensure a seamless experience for US. OmniPod users and healthcare providers who would like to use the new platform.